Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
GOP Rep. And Psychedelics Supporter Denounces 'Gerontocracy' At Congressional Level
July 07, 2023
Tags
Psychedelic/Assisted Therapies
Market News
Markets
From
Benzinga
Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal
July 07, 2023
Tickers
FLHLF
Tags
Benzinga
Psychedelics
Licensing Deal
From
Benzinga
Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures
July 06, 2023
Tickers
CMPS
Tags
MAPS PBC
FDA
Psychedelics
From
Benzinga
PharmAla's Australian JV Cortexa Orders First Commercial MDMA & Psilocybin Shipment
July 05, 2023
Tickers
PMBHF
Tags
Psychedelics
Benzinga
Contracts
From
Benzinga
Small Pharma Implements Costs Cut: New R&D Strategy And Management Team Change
July 05, 2023
Tickers
DMTTF
Tags
Markets
Cannabis
Market News
From
Benzinga
Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next
July 05, 2023
Tickers
AWKNF
Tags
AWKNF
alcohol use disorder
Ketamine Therapy
From
Benzinga
80% Of US Voters Support Easing Research Restrictions, Plus Other Insights From UC-Berkeley Poll
July 05, 2023
Tags
Legal
Management
News
From
Benzinga
Inside UC Berkeley's Nation-Representative Psychedelics Survey: Unveiling Unexpected Data
July 05, 2023
Tags
New Berkeley Center for the Science of Psychedelics (BCSP)
Psychedelics
Interview
From
Benzinga
COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital
July 05, 2023
Tickers
ATAI
CMPS
HTGC
Tags
treatment/resistant depression
HTGC
Financing
From
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
Tickers
BETRF
CYBN
DMTTF
DSNKY
Tags
PHRRF
SEMR
Management
From
Benzinga
Harnessing The Power Of 5-MeO-DMT For Women Trauma Survivors: A Specialized Retreat
July 03, 2023
Tags
Psychedelics
News
Management
From
Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
July 02, 2023
Tags
News
Exclusives
Management
From
Benzinga
Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses
June 29, 2023
Tickers
DMTTF
Tags
Psychedelics
Benzinga
Top Stories
From
Benzinga
Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3
June 29, 2023
Tickers
MSSTF
REUN
Tags
Guidance
Psychedelic/Assisted Therapies
Market News
From
Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
June 28, 2023
Tickers
LOBEF
Tags
Markets
Cannabis
Chronic Cluster Headaches
From
Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
Tickers
BETRF
PHRRF
Tags
Psychedelics
Benzinga
FDA
From
Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
June 28, 2023
Tickers
CYBN
Tags
News
Penny Stocks
Management
From
Benzinga
Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets
June 27, 2023
Tickers
FTHWF
PHRRF
Tags
Psychedelics
Benzinga
Microneedle Patch
From
Benzinga
Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
June 27, 2023
Tickers
DSNKY
Tags
Psylo
Non/Hallucinogenic Psychedelic Compound
DSNKY
From
Benzinga
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
June 27, 2023
Tickers
MSSTF
Tags
Market News
Cannabis
Markets
From
Benzinga
MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
June 27, 2023
Tickers
MNMD
Tags
Management
MNMD
News
From
Benzinga
$100M Investment & Donation To Psychedelics Research From Toms Shoes Founder Blake Mycoskie
June 27, 2023
Tags
Psychedelic/Assisted Therapies
Market News
Cannabis
From
Benzinga
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
Tickers
NUMIF
OPTHF
PMBHF
Tags
Market News
Cannabis
Markets
From
Benzinga
Johns Hopkins Researchers Find Psychedelics Reopen The Social Reward Learning Period
June 19, 2023
Tags
Psychedelic/Assisted Therapies
Cannabis
Markets
From
Benzinga
CNN Goes Psychedelic: Anderson Cooper's Upcoming Show On Magic Mushrooms
June 16, 2023
Tickers
NFLX
Tags
Benzinga
How To Change Your Mind
Psychedelics
From
Benzinga
Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
June 15, 2023
Tickers
AWKNF
Tags
AWKNF
Benzinga
Psychedelics
From
Benzinga
Nevada Governor Passes Psychedelics Bill To Form New Working Group And Future Regulated Access
June 15, 2023
Tags
Legal
Benzinga
Psychedelics
From
Benzinga
Federal Psychedelics: $75M Grant Program, NIDA's Special Interest In State & Local Reform
June 14, 2023
Tags
Psychedelic/Assisted Therapies
NIDA/funded trial
Government
From
Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
June 13, 2023
Tickers
PMBHF
Tags
Psychedelics
Benzinga
Contracts
From
Benzinga
Silo Pharma's New Ketamine Implant For Fibromyalgia And Chronic Pain Is In The Making
June 13, 2023
Tickers
SILO
TRYPF
Tags
Market News
Cannabis
Markets
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.